Works by Wallenius, Kristina
Results: 13
Pharmacological treatment with FGF21 strongly improves plasma cholesterol metabolism to reduce atherosclerosis.
- Published in:
- Cardiovascular Research, 2022, v. 118, n. 2, p. 489, doi. 10.1093/cvr/cvab076
- By:
- Publication type:
- Article
Interleukin-6 Levels in the Central Nervous System Are Negatively Correlated with Fat Mass in Overweight/Obese Subjects.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2003, v. 88, n. 9, p. 4379, doi. 10.1210/jc.2002-021733
- By:
- Publication type:
- Article
FGF21 protects against hepatic lipotoxicity and macrophage activation to attenuate fibrogenesis in nonalcoholic steatohepatitis.
- Published in:
- eLife, 2023, p. 1, doi. 10.7554/eLife.83075
- By:
- Publication type:
- Article
Non‐clinical and first‐in‐human characterization of ECC5004/AZD5004, a novel once‐daily, oral small‐molecule GLP‐1 receptor agonist.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 551, doi. 10.1111/dom.16047
- By:
- Publication type:
- Article
Liver-Derived IGF-I is of Importance for Normal Carbohydrate and Lipid Metabolism.
- Published in:
- Diabetes, 2001, v. 50, n. 7, p. 1539, doi. 10.2337/diabetes.50.7.1539
- By:
- Publication type:
- Article
Pharmacological PPARα Activation Markedly Alters Plasma Turnover of the Amino Acids Glycine, Serine and Arginine in the Rat.
- Published in:
- PLoS ONE, 2014, v. 9, n. 12, p. 1, doi. 10.1371/journal.pone.0113328
- By:
- Publication type:
- Article
Effects of Liver-Derived Insulin-Like Growth Factor I on Bone Metabolism in Mice.
- Published in:
- Journal of Bone & Mineral Research, 2002, v. 17, n. 11, p. 1977, doi. 10.1359/jbmr.2002.17.11.1977
- By:
- Publication type:
- Article
Interleukin-6-deficient mice develop mature-onset obesity.
- Published in:
- Nature Medicine, 2002, v. 8, n. 1, p. 75, doi. 10.1038/nm0102-75
- By:
- Publication type:
- Article
The PPARα/γ Agonist, Tesaglitazar, Improves Insulin Mediated Switching of Tissue Glucose and Free Fatty Acid Utilization In Vivo in the Obese Zucker Rat.
- Published in:
- PPAR Research, 2013, p. 1, doi. 10.1155/2013/305347
- By:
- Publication type:
- Article
Chronotherapy with a glucokinase activator profoundly improves metabolism in obese Zucker rats.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 668, p. 1, doi. 10.1126/scitranslmed.abh1316
- By:
- Publication type:
- Article
Turnover Modeling of Non-Esterified Fatty Acids in Rats After Multiple Intravenous Infusions of Nicotinic Acid.
- Published in:
- Dose-Response, 2009, v. 7, n. 3, p. 247, doi. 10.2203/dose-response.08-028.Isaksson
- By:
- Publication type:
- Article
Identification of Proteins Associated with the Early Restoration of Insulin Sensitivity After Biliopancreatic Diversion.
- Published in:
- 2020
- By:
- Publication type:
- journal article
1881-P: The SGLT2 Inhibitor Dapagliflozin Improves Glucose Control and Enhances Liver Fatty Acid Oxidation and Ketone Body Formation in Insulin Resistant Obese Zucker Rats.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1881-P
- By:
- Publication type:
- Article